Generic Name and Formulations:
Ofloxacin 0.3%; oph. soln; contains benzalkonium chloride.
Indications for OCUFLOX:
Susceptible infections of the conjuctiva and corneal ulcer.
Adults and Children:
<1yr: not established. ≥1yr: Conjunctivitis: 1–2 drops every 2–4hrs for 2 days, then 4 times daily for 5 more days. Corneal ulcer: 1–2 drops every 30mins while awake and at 4hrs & 6hrs after retiring for sleep for 2 days, then 1–2 drops every 1hr while awake for days 3 through 7–9, then 1–2 drops 4 times daily through treatment completion.
Discontinue if superinfection or hypersensitivity occurs. Pregnancy. Nursing mothers: not recommended.
Possible potentiation of theophylline, caffeine, oral anticoagulants, cyclosporine if systemic absorption occurs.
Ocular burning/discomfort, redness, itching, chemical conjunctivitis/keratitis, ocular/facial edema, foreign body sensation, photophobia, blurred vision, tearing, dryness, eye pain.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age